A news story invented by one of the IVERCAR protocol researchers. Where is the formal paper, that would be convincing to scientists and physicians elsewhere?
The National Library of Medicine accepted the protocols developed in our country and registered them for their worldwide availability.
Looking back, it all looks like a movie plot. Back in February 2020, already retired, I contacted Professor Roberto Hirsch (about to retire) because I was thinking of a drug combination that could be effective against COVID. He was somewhat skeptical, as it was not among his plans to embark on further investigations. However, I prepared a preliminary Article on the subject, and published it with the "signature" of both.
When Hirsch found out, relatives tell me that he read the article in detail, in order to scold me for my unconsulted and reckless decision. When he finished reading it (always according to allegations) they say he was fascinated: it seemed so simple and effective at the same time that it could really work.
It needed some refinement, of course. Between the two of us, we began to visit Laboratories, to get free samples of the drugs we needed to do the tests. A couple of younger doctors - of whom both of us had long been teachers - joined to run the trials.
Thus, the IVER.CAR and IDEA Protocols - for prophylaxis and treatment in COVID 19, respectively - were born, which were carried out with great success. At that point, the plot began to get complicated: the Health Authorities received the works without much interest, which they neatly saved without giving out.
Disconcerted, we began an exhausting work “from the bottom up”, contacting Professionals from all over the country who were interested in the results, and began to replicate them with equal success.
Treatments for infected patients differ according to the type of case. In mild patients,ivermectinis given at a dose of 200 micrograms per kilogram of weight and aspirin to prevent hypercoagulability. In moderate cases, the dose ofivermectinis 450 micrograms and, in addition to aspirin, injectable dexamethasone, an anti-inflammatory drug, is added to prevent hyperinflammation in the lungs. In severe cases, theivermectindose is increased to 600 micrograms, aspirin is replaced by enoxaparin, and dexamethasone is maintained.
In the case of health personnel, a nasal spray and a few oral drops are administered to protect the nose and mouth.
?? I thought the oral ivermectin went away with the revision of the IVERCAR protocol in July (IIRC)?!
Thus, these treatments are carried out today in Hospitals and Medical Centers in Corrientes, Salta, Jujuy, Tucumán, Chubut, CABA, Santa Fé, etc., achieving what -until then- unthinkable: the resolution of most of the pictures in 48- 72 hours, and the protection of all Health Agents who carry it out, even in the midst of massive infections. Our advice has been required in Peru, El Salvador, Colombia, Venezuela, etc., always unofficially, but with very promising responses.
We elevated the Protocols to the US National Library of Medicine, which accepted them as valuable and inscribed them for worldwide availability.
The two Professors are Héctor Carvallo (Former Director of the Ezeiza Hospital and former Professor of the University of Buenos Aires), and Roberto Hirsch (Director of the Infectology Department of the Muñíz Hospital and of the Infectology Specialist Career at the UBA).
Today, we are required by different Universities and Centers to present their results, and we always obtain the support of the audiences.
[-] TrumpLyftAlles | 2 points | Oct 29 2020 17:03:09
A news story invented by one of the IVERCAR protocol researchers. Where is the formal paper, that would be convincing to scientists and physicians elsewhere?
The National Library of Medicine accepted the protocols developed in our country and registered them for their worldwide availability.
Looking back, it all looks like a movie plot. Back in February 2020, already retired, I contacted Professor Roberto Hirsch (about to retire) because I was thinking of a drug combination that could be effective against COVID. He was somewhat skeptical, as it was not among his plans to embark on further investigations. However, I prepared a preliminary Article on the subject, and published it with the "signature" of both.
When Hirsch found out, relatives tell me that he read the article in detail, in order to scold me for my unconsulted and reckless decision. When he finished reading it (always according to allegations) they say he was fascinated: it seemed so simple and effective at the same time that it could really work.
It needed some refinement, of course. Between the two of us, we began to visit Laboratories, to get free samples of the drugs we needed to do the tests. A couple of younger doctors - of whom both of us had long been teachers - joined to run the trials.
Thus, the IVER.CAR and IDEA Protocols - for prophylaxis and treatment in COVID 19, respectively - were born, which were carried out with great success. At that point, the plot began to get complicated: the Health Authorities received the works without much interest, which they neatly saved without giving out.
Disconcerted, we began an exhausting work “from the bottom up”, contacting Professionals from all over the country who were interested in the results, and began to replicate them with equal success.
Treatments for infected patients differ according to the type of case. In mild patients, ivermectin is given at a dose of 200 micrograms per kilogram of weight and aspirin to prevent hypercoagulability. In moderate cases, the dose of ivermectin is 450 micrograms and, in addition to aspirin, injectable dexamethasone, an anti-inflammatory drug, is added to prevent hyperinflammation in the lungs. In severe cases, the ivermectin dose is increased to 600 micrograms, aspirin is replaced by enoxaparin, and dexamethasone is maintained.
In the case of health personnel, a nasal spray and a few oral drops are administered to protect the nose and mouth.
?? I thought the oral ivermectin went away with the revision of the IVERCAR protocol in July (IIRC)?!
Thus, these treatments are carried out today in Hospitals and Medical Centers in Corrientes, Salta, Jujuy, Tucumán, Chubut, CABA, Santa Fé, etc., achieving what -until then- unthinkable: the resolution of most of the pictures in 48- 72 hours, and the protection of all Health Agents who carry it out, even in the midst of massive infections. Our advice has been required in Peru, El Salvador, Colombia, Venezuela, etc., always unofficially, but with very promising responses.
We elevated the Protocols to the US National Library of Medicine, which accepted them as valuable and inscribed them for worldwide availability.
The two Professors are Héctor Carvallo (Former Director of the Ezeiza Hospital and former Professor of the University of Buenos Aires), and Roberto Hirsch (Director of the Infectology Department of the Muñíz Hospital and of the Infectology Specialist Career at the UBA).
Today, we are required by different Universities and Centers to present their results, and we always obtain the support of the audiences.
permalink